Mumbai, May 1 (PTI): Maharashtra's Food & Drug Administration (FDA) has ordered the filing of cases against online retailer Snapdeal.com, its CEO, directors and distributors, for allegedly selling prescription drugs online.

FDA Commissioner Harshadeep Kamble said investigations into other e-commerce giants such as Flipkart and Amazon are also under progress to ascertain if they are involved in such sales.

Last month, FDA had raided premises of Snapdeal here following complaints about sale of medicines, including prescription drugs, through its website.

Kamble told reporters that FDA has ordered the filing of a first information report against all persons concerned, including Snapdeal CEO Kunal Bahl, other directors of the company and distributors of the drugs.

When contacted, a Snapdeal spokesperson said: “… we are assisting the FDA team in this investigation and we will continue to do so. We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them.”

Kamble said Jasper Infotech Pvt Ltd, through Snapdeal.com, offered/ exhibited for sale Vigora Tablets 100, which contains Sildenafil citrate. The drug is used to treat erectile dysfunction and can be sold only against the prescription of a registered medical practitioner.

He said the drug was sold by Mittal Pharma of Kota, Rajasthan, a seller in agreement with Jasper, without prescription.

”The drug was also sold by Rishabh Enterprises, New Delhi, a seller in agreement with Jasper, to a customer Amrut Bhagat of Panvel in Maharashtra's Raigad district through a courier in agreement with Jasper, who collected the cost of drug for Jasper,” he said.

He said Jasper Infotech through Snapdeal.com exhibited and offered for sale female contraceptive pills.